TARGET AUDIENCE
This accredited activity has been designed for oncology, managed care and specialty pharmacists.This accredited activity has been designed for oncology, managed care and specialty pharmacists.
GOAL
To provide oncology, managed care, and specialty pharmacists with advanced knowledge about optimal and emerging immune-oncology treatment options for adult patients with genitourinary cancers, such that they can optimize patient care.
EDUCATIONAL OBJECTIVES
Upon completion of this program, participants should be better able to:
• Discuss current and emerging immune checkpoint inhibitor (ICI) use in genitourinary cancer treatment alone and in combination regimens
• Identify challenges to and best practices for ICI use in genitourinary cancer treatment
• Demonstrate approaches to effectively recognize and manage immune-related adverse events of immunotherapies alone and in combination regimens for genitourinary cancer treatment
Postgraduate Healthcare Education, LLC ("PHE") provides Power-Pak C.E.® educational programs for the broad spectrum of healthcare professions. Professional medical and pharmaceutical education constitutes PHE's core activity. PHE continues to successfully produce continuing education programs for all professional healthcare disciplines including pharmacists, pharmacy technicians, physicians, nurses, physician assistants, and nurse practitioners.
